Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease

dc.creatorAcquarone, Mariana
dc.creatorMelo, Thiago M. de
dc.creatorMeireles, Fernanda
dc.creatorMoreira, Jordano Brito
dc.creatorOliveira, Gabriel
dc.creatorFerreira, Sergio T.
dc.creatorCastro, Newton G.
dc.creatorTovar-Moll, Fernanda
dc.creatorHouzel, Jean-Christophe
dc.creatorRehen, Stevens K.
dc.date.accessioned2016-04-18T14:20:55Z
dc.date.accessioned2023-09-05T11:51:00Z
dc.date.available2016-04-18T14:20:55Z
dc.date.available2023-09-05T11:51:00Z
dc.date.created2016-04-18T14:20:55Z
dc.date.issued2015
dc.identifierACQUARONE, Mariana; et al. Mitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease. Frontiers in Cellular Neuroscience, v.9, Article 97, 12p, Apr. 2015.
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/13845
dc.identifier10.3389/fncel.2015.00097
dc.identifier1662-5102
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8643450
dc.languageeng
dc.publisherFrontiers Media
dc.rightsopen access
dc.titleMitomycin-treated undifferentiated embryonic stem cells as a safe and effective therapeutic strategy in a mouse model of Parkinson’s disease
dc.typeArticle


Este ítem pertenece a la siguiente institución